Clinical trialNCT04739072RecruitingObservational

Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

SponsorM.D. Anderson Cancer CenterEnrollment1,000Colorectal AdenocarcinomaStage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8Stage IIA Colorectal Cancer AJCC v8Stage IIB Colorectal Cancer AJCC v8Stage IIC Colorectal Cancer AJCC v8+8 more conditions

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come back or spread. Tumors shed DNA and other cancer related chemicals into the blood that can be identified and studied further to provide information about the cancer. Information gathered from this study may help researchers better understand if ctDNA found in the blood can predict whether colorectal cancer may come back or spread.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Arvind Dasari
M.D. Anderson Cancer Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Banner - Md Anderson Cancer Center
Gilbert, Arizona, United States
Terminated
Baptist- Md Anderson Cancer Center
Jacksonville, Florida, United States
Terminated
the Queen'S Medical Center
Honolulu, Hawaii, United States
Terminated
St. Luke'S Cancer Institute
Boise, Idaho, United States
Terminated
Cooper Hospital Univ Med Ctr.
Camden, New Jersey, United States
Terminated
Ut Southwestern/simmons Cancer Center-Dallas
Dallas, Texas, United States
Terminated
Houston Methodist Cancer Center
Houston, Texas, United States
Terminated
M D Anderson Cancer Center
Houston, Texas, United States
Arvind Dasari
Recruiting
Ut Health San Antonio Md Anderson Cancer Center
San Antonio, Texas, United States
Terminated
Baylor Scott & White Research Institute
Temple, Texas, United States
Terminated

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 22 Nov 2019
Primary completion: 31 Dec 2028
Completion: 31 Dec 2028
Last update posted: 29 May 2026
Registered enrollment: 1,000
Registry id: NCT04739072

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.